• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用液相色谱-串联质谱技术测定大鼠血浆中的鲁比前列酮分析

Determination of Ruboxistaurin analysis in rat plasma utilizing LC-MS/MS technique.

作者信息

AlQuadeib Bushra T, Aleanizy Fadilah S, Alqahtani Fulwah Y, Alshammari Rehab A, Aldarwesh Amal, Alsarra Ibrahim

机构信息

Department of Pharmaceutics, College of Pharmacy, King Saud University, Saudi Arabia, P.O. Box 84428, Riyadh 11671, Saudi Arabia.

Department of Optometry, College of Applied Medical Sciences, King Saud University, P.O. 11671, Riyadh 11671, Saudi Arabia.

出版信息

Saudi Pharm J. 2023 Apr;31(4):547-553. doi: 10.1016/j.jsps.2023.02.007. Epub 2023 Feb 25.

DOI:10.1016/j.jsps.2023.02.007
PMID:37063445
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10102418/
Abstract

BACKGROUND

Ruboxistaurin (RBX) used to treat retinopathy in diabetic patients which caused by microvascular damage and leakage which contributes to visual loss. There are no published studies on the use of liquid chromatography-tandem mass spectrometry for development and validation of a simple, sensitive, and accurate method for measuring RBX in rat plasma.

METHOD

Chromatographic separation of RBX was achieved using ultra-performance liquid chromatography. Multiple-reaction monitoring quantification used RBX [M + H] + ion at / 469.18 and daughter ions at / 84, 58.12, and 98.10. Atorvastatin was used as internal standard (IS), has a single daughter ion, and was identified using / 559.6 → 249.9. Validation of the liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for RBX in rat plasma for linearity (greater than0.997) was carried out at 25-1000 ng/mL.

RESULTS

In rat plasma, the accuracy was within 3.4%, and the intra- and inter-day precision was within 11.8%. Stability, recovery, and matrix effect were all within acceptable limits. The drug retention time (0.85 ± 0.03 min) was remarkably short.

CONCLUSION

The method developed in the current study is suitable to quantify RBX in plasma or bulk doses.

摘要

背景

鲁比前列酮(RBX)用于治疗糖尿病患者因微血管损伤和渗漏导致的视网膜病变,这种损伤和渗漏会导致视力丧失。目前尚无关于使用液相色谱 - 串联质谱法开发和验证一种简单、灵敏且准确的大鼠血浆中RBX测定方法的公开研究。

方法

使用超高效液相色谱实现RBX的色谱分离。多反应监测定量采用RBX [M + H]+离子,质荷比为469.18,子离子质荷比为84、58.12和98.10。阿托伐他汀用作内标(IS),有一个单一子离子,通过质荷比559.6→249.9进行鉴定。在25 - 1000 ng/mL范围内对大鼠血浆中RBX的液相色谱 - 串联质谱(LC - MS/MS)方法进行线性验证(大于0.997)。

结果

在大鼠血浆中,准确度在3.4%以内,日内和日间精密度在11.8%以内。稳定性、回收率和基质效应均在可接受范围内。药物保留时间(0.85±0.03分钟)非常短。

结论

本研究中开发的方法适用于定量血浆或大剂量中的RBX。

相似文献

1
Determination of Ruboxistaurin analysis in rat plasma utilizing LC-MS/MS technique.利用液相色谱-串联质谱技术测定大鼠血浆中的鲁比前列酮分析
Saudi Pharm J. 2023 Apr;31(4):547-553. doi: 10.1016/j.jsps.2023.02.007. Epub 2023 Feb 25.
2
A simple LC-MS/MS method for simultaneous determination of cilostazol and ambroxol in Sprague-Dawley rat plasma and its application to drug-drug pharmacokinetic interaction study following oral delivery in rats.一种简单的 LC-MS/MS 法,用于同时测定 Sprague-Dawley 大鼠血浆中的西洛他唑和氨溴索,并将其应用于大鼠口服给药后的药物相互作用的药代动力学研究。
J Chromatogr B Analyt Technol Biomed Life Sci. 2021 Aug 1;1179:122766. doi: 10.1016/j.jchromb.2021.122766. Epub 2021 May 21.
3
Development and Validation of High-Throughput Bioanalytical Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) Method for the Quantification of Newly Synthesized Antitumor Carbonic Anhydrase Inhibitors in Human Plasma.开发和验证高通量生物分析液相色谱-串联质谱(LC-MS/MS)方法,用于定量人血浆中新合成的抗肿瘤碳酸酐酶抑制剂。
Molecules. 2020 Dec 6;25(23):5753. doi: 10.3390/molecules25235753.
4
Determination of xanthatin by ultra high performance liquid chromatography coupled with triple quadrupole mass spectrometry: application to pharmacokinetic study of xanthatin in rat plasma.超高效液相色谱-三重四极杆质谱联用测定苍耳素:应用于苍耳素在大鼠血浆中的药代动力学研究
J Chromatogr B Analyt Technol Biomed Life Sci. 2014 Feb 1;947-948:57-61. doi: 10.1016/j.jchromb.2013.12.006. Epub 2013 Dec 18.
5
Quantification of a New Anti-Cancer Molecule MJC13 Using a Rapid, Sensitive, and Reliable Liquid Chromatography-Tandem Mass Spectrometry Method.使用快速、灵敏且可靠的液相色谱-串联质谱法对新型抗癌分子MJC13进行定量分析。
Am J Mod Chromatogr. 2014;1(1):1-11.
6
Development, validation and method stability study of a LC-MS method to quantify leuprolide (Hormone analog) in human plasma.建立并验证一种 LC-MS 方法,用于定量检测人血浆中的促黄体生成素释放激素类似物(激素类似物),并对该方法的稳定性进行研究。
J Chromatogr B Analyt Technol Biomed Life Sci. 2020 Dec 1;1160:122345. doi: 10.1016/j.jchromb.2020.122345. Epub 2020 Aug 27.
7
High-throughput LC-MS/MS Method for Simultaneous Determination of Pantoprazole and Atorvastatin in Rat Plasma: Application to a Pharmacokinetic Interaction Study.基于 LC-MS/MS 的同时测定大鼠血浆中泮托拉唑和阿托伐他汀浓度的方法:在药代动力学相互作用研究中的应用。
Curr Drug Metab. 2021;22(6):481-490. doi: 10.2174/1389200222666210520090632.
8
[Feasibility of the determination of plasma vardenafil level in rat by performance liquid chromatography-tandem mass spectrometry].[高效液相色谱-串联质谱法测定大鼠血浆伐地那非水平的可行性]
Zhonghua Xin Xue Guan Bing Za Zhi. 2020 Jun 24;48(6):507-512. doi: 10.3760/cma.j.cn112148-20200307-00170.
9
UPLC-MS/MS determination and gender-related pharmacokinetic study of five active ingredients in rat plasma after oral administration of Eucommia cortex extract.超高效液相色谱-串联质谱法测定杜仲皮提取物口服给药后大鼠血浆中5种活性成分及其性别相关的药代动力学研究
J Ethnopharmacol. 2015 Jul 1;169:145-55. doi: 10.1016/j.jep.2015.04.007. Epub 2015 Apr 22.
10
Development and Validation of a LC-MS/MS Method for Quantification of Mobocertinib (TAK-788) in Plasma and its Application to Pharmacokinetic Study in Rats.建立和验证 LC-MS/MS 法测定血浆中莫博替尼(TAK-788)的浓度及其在大鼠药代动力学研究中的应用。
Comb Chem High Throughput Screen. 2021;24(9):1410-1416. doi: 10.2174/1386207323999201103215736.

引用本文的文献

1
Key Therapeutic Targets to Treat Hyperglycemia-Induced Atherosclerosis Analyzed Using a Petri Net-Based Model.使用基于Petri网的模型分析治疗高血糖诱导动脉粥样硬化的关键治疗靶点。
Metabolites. 2023 Dec 8;13(12):1191. doi: 10.3390/metabo13121191.

本文引用的文献

1
Retinal Delivery of the Protein Kinase C-β Inhibitor Ruboxistaurin Using Non-Invasive Nanoparticles of Polyamidoamine Dendrimers.使用聚酰胺胺树枝状大分子的非侵入性纳米颗粒将蛋白激酶C-β抑制剂鲁比前列素递送至视网膜。
Pharmaceutics. 2022 Jul 11;14(7):1444. doi: 10.3390/pharmaceutics14071444.
2
Tamoxifen a pioneering drug: An update on the therapeutic potential of tamoxifen derivatives.他莫昔芬——一种开创性药物:他莫昔芬衍生物治疗潜力的最新进展
Eur J Med Chem. 2018 Jan 1;143:515-531. doi: 10.1016/j.ejmech.2017.11.056. Epub 2017 Nov 24.
3
Direct and Systemic Administration of a CNS-Permeant Tamoxifen Analog Reduces Amphetamine-Induced Dopamine Release and Reinforcing Effects.一种可透过中枢神经系统的他莫昔芬类似物的直接和全身给药可减少苯丙胺诱导的多巴胺释放及强化作用。
Neuropsychopharmacology. 2017 Sep;42(10):1940-1949. doi: 10.1038/npp.2017.95. Epub 2017 May 11.
4
The Protein Kinase C Inhibitor: Ruboxistaurin.蛋白激酶C抑制剂:鲁比前列酮
Dev Ophthalmol. 2016;55:295-301. doi: 10.1159/000431204. Epub 2015 Oct 26.
5
Ruboxistaurin for the treatment of diabetic peripheral neuropathy: a systematic review of randomized clinical trials.罗苏司他丁治疗糖尿病周围神经病变的系统评价:随机临床试验研究。
Diabetes Metab J. 2013 Oct;37(5):375-84. doi: 10.4093/dmj.2013.37.5.375. Epub 2013 Oct 17.
6
The effect of the oral PKC β inhibitor ruboxistaurin on vision loss in two phase 3 studies.口服蛋白激酶 Cβ抑制剂罗格列酮在两项 3 期研究中对视力丧失的影响。
Invest Ophthalmol Vis Sci. 2013 Mar 11;54(3):1750-7. doi: 10.1167/iovs.12-11055.
7
The beta-specific protein kinase C inhibitor ruboxistaurin (LY333531) suppresses glucose-induced adhesion of human monocytes to endothelial cells in vitro.β特异性蛋白激酶C抑制剂鲁伯斯塔林(LY333531)在体外可抑制葡萄糖诱导的人单核细胞与内皮细胞的黏附。
J Diabetes Sci Technol. 2007 Nov;1(6):929-35. doi: 10.1177/193229680700100620.
8
Targeting the protein kinase C family in the diabetic kidney: lessons from analysis of mutant mice.靶向糖尿病肾病中的蛋白激酶C家族:来自突变小鼠分析的经验教训。
Diabetologia. 2009 May;52(5):765-75. doi: 10.1007/s00125-009-1278-y. Epub 2009 Feb 24.
9
Selective PKC beta inhibition with ruboxistaurin and endothelial function in type-2 diabetes mellitus.鲁伯斯塔林对蛋白激酶Cβ的选择性抑制作用与2型糖尿病患者的内皮功能
Cardiovasc Drugs Ther. 2009 Feb;23(1):17-24. doi: 10.1007/s10557-008-6144-5. Epub 2008 Oct 24.
10
Disposition of [14C]ruboxistaurin in humans.[14C]鲁比前列酮在人体内的处置情况。
Drug Metab Dispos. 2006 Nov;34(11):1909-17. doi: 10.1124/dmd.106.009894. Epub 2006 Aug 8.